Revenue: The sum of all revenue fields included for a company's operating activities.
PTC Therapeutics, Inc. (PTCT) had Revenue of $272.55M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$272.55M |
$-2.81M |
|
$28.03M |
|
$244.52M |
|
$227.59M |
|
$44.96M |
|
$-47.42M |
|
$-2.46M |
|
$-2.46M |
|
$-2.81M |
|
$-2.81M |
|
$-2.81M |
|
$-2.81M |
|
$44.96M |
|
$57.49M |
|
82.52M |
|
82.52M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$2.25B |
|
$52.74M |
|
$615.10M |
|
$2.87B |
|
$923.60M |
|
$2.02B |
|
$2.13B |
|
$3.05B |
|
$-180.47M |
|
$-643.49M |
|
$-180.47M |
|
82.88M |
|
| Cash Flow Statement Financials | |
$-59.04M |
|
$-93.74M |
|
$6.40M |
|
$998.33M |
|
$850.43M |
|
$-147.90M |
|
$23.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.44 |
|
-- |
|
-- |
|
1.10 |
|
-14.52 |
|
89.72% |
|
16.50% |
|
16.50% |
|
-- |
|
-0.90% |
|
-1.03% |
|
$-60.24M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.37 |
|
1.24 |
|
72.62 |
|
1.56% |
|
0.44% |
|
-0.10% |
|
-0.15% |
|
$-2.18 |
|
$-0.73 |
|
$-0.72 |
|